A randomized trial of Evidence-based OutReach (EBOR): Rationale and design

被引：19

作者：

Freemantle, N ^{[1
]}

Eccles, M

Wood, J

Mason, J

Nazareth, I

Duggan, C

Young, P

Haines, A

Drummond, M

Russell, I

Walley, T

机构：

[1] Univ York, Ctr Hlth Econ, Med Evaluat Grp, York YO10 5DD, N Yorkshire, England

[2] Newcastle Univ, Ctr Hlth Serv Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[3] Univ York, Dept Hlth Sci & Clin Evaluat, York YO1 5DD, N Yorkshire, England

[4] UCL, Dept Primary Care & Populat Sci, London, England

[5] Royal Free Sch Med, London, England

[6] Univ Liverpool, Dept Pharmacol, Liverpool L69 3BX, Merseyside, England

来源：

CONTROLLED CLINICAL TRIALS | 1999年 / 20卷 / 05期

关键词：

evidence-based clinical practice guidelines; educational outreach visits; unit of analysis; pharmacists;

D O I：

10.1016/S0197-2456(99)00023-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

There is increasing interest in evaluating the methods used to implement the findings from medical research. This paper describes the Evidence-based OutReach (EBOR) trial, which is the first large randomized study in the United Kingdom that will evaluate the effectiveness and efficiency of educational outreach visits by trained pharmacists who are delivering messages derived from four evidence-based clinical practice guidelines. General practices form the unit of allocation and analysis. The study design addresses important factors that may influence the effectiveness of the intervention, such as the pharmacist who delivers the messages, the health authority in which practices are located, and the size of a practice. (C) Elsevier Science Inc. 1999.

引用

页码：479 / 492

页数：14

共 24 条

[1]

[Anonymous], 1997, CM3807

[2] A COMPARISON OF RESULTS OF METAANALYSES OF RANDOMIZED CONTROL TRIALS AND RECOMMENDATIONS OF CLINICAL EXPERTS - TREATMENTS FOR MYOCARDIAL-INFARCTION [J].

ANTMAN, EM ;

LAU, J ;

KUPELNICK, B ;

MOSTELLER, F ;

CHALMERS, TC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (02) :240-248

[3] Lessons from international experience in controlling pharmaceutical expenditure .2. Influencing doctors [J].

Bloor, K ;

Freemantle, N .

BRITISH MEDICAL JOURNAL, 1996, 312 (7045) :1525-1527

[4] FACTORIAL AND RECIPROCAL CONTROL DESIGNS [J].

BYAR, DP .

STATISTICS IN MEDICINE, 1990, 9 (1-2) :55-64

[5]

DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700

[6] EVIDENCE FOR THE EFFECTIVENESS OF CME - A REVIEW OF 50 RANDOMIZED CONTROLLED TRIALS [J].

DAVIS, DA ;

THOMSON, MA ;

OXMAN, AD ;

HAYNES, RB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (09) :1111-1117

[7] RANDOMIZATION BY GROUP IN STUDYING THE EFFECT OF DRUG INFORMATION IN PRIMARY CARE [J].

DIWAN, VK ;

ERIKSSON, B ;

STERKY, G ;

TOMSON, G .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (01) :124-130

[8] CLUSTER RANDOMIZATION IN LARGE PUBLIC-HEALTH TRIALS - THE IMPORTANCE OF ANTECEDENT DATA [J].

DUFFY, SW ;

SOUTH, MC ;

DAY, NE .

STATISTICS IN MEDICINE, 1992, 11 (03) :307-316

[9] North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care [J].

Eccles, M ;

Freemantle, N ;

Mason, J .

BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7140) :1303-1309

[10] North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care [J].

Eccles, M ;

Freemantle, N ;

Mason, J .

BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1232-1235

← 1 2 3 →